Embecta Corp. Share Price

Equities

EMBC

US29082K1051

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq 21:00:00 26/04/2024 BST 5-day change 1st Jan Change
10.31 USD -0.87% Intraday chart for Embecta Corp. -2.92% -45.54%
Sales 2024 * 1.11B 88.89B Sales 2025 * 1.11B 89.21B Capitalization 594M 47.52B
Net income 2024 * 51M 4.08B Net income 2025 * 99M 7.93B EV / Sales 2024 * 1.55 x
Net Debt 2024 * 1.13B 90.61B Net Debt 2025 * 1.01B 81.02B EV / Sales 2025 * 1.44 x
P/E ratio 2024 *
11.7 x
P/E ratio 2025 *
6.12 x
Employees 2,200
Yield 2024 *
5.42%
Yield 2025 *
5.39%
Free-Float 99.53%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.87%
1 week-2.92%
Current month-22.31%
1 month-16.52%
3 months-40.40%
6 months-30.67%
Current year-45.54%
More quotes
1 week
10.29
Extreme 10.29
10.98
1 month
9.93
Extreme 9.925
13.60
Current year
9.93
Extreme 9.925
19.79
1 year
9.93
Extreme 9.925
32.00
3 years
0.00
Extreme 0
49.00
5 years
0.00
Extreme 0
49.00
10 years
0.00
Extreme 0
49.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 56 21/03/22
Director of Finance/CFO 51 21/03/22
Chief Tech/Sci/R&D Officer 60 30/09/21
Members of the board TitleAgeSince
Director/Board Member 68 31/03/22
Director/Board Member 60 31/03/22
Director/Board Member 58 19/03/22
More insiders
Date Price Change Volume
26/04/24 10.31 -0.87% 264,117
25/04/24 10.4 -4.50% 488,927
24/04/24 10.89 +0.09% 284,241
23/04/24 10.88 +1.49% 357,508
22/04/24 10.72 +0.94% 408,666

Delayed Quote Nasdaq, April 26, 2024 at 09:00 pm

More quotes
Embecta Corp. is a global medical device company. The Company is focused on providing solutions to people living with diabetes. The Company has a portfolio of products, including a range of pen needles, syringes and safety injection devices, which are complemented by its digital application designed to assist people with managing their diabetes. Its pen needles are sterile, single-use, medical devices, designed to be used in conjunction with pen injectors that inject insulin or other diabetes medications. The Company also sells safety pen needles, which have shields on both ends of the cannula that automatically deploy after the injection to help prevent needlestick exposure and injury during injection and disposal. In addition to pen needles, it sells sterile, single-use insulin syringes, which are used to inject insulin drawn from insulin vials. It distributes its products through a variety of channels, including retail, hospitals, pharmacies and other institutional channels.
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
4
Last Close Price
10.31 USD
Average target price
16.5 USD
Spread / Average Target
+60.04%
Consensus